A PHASE 1/IIA STUDY OF DECITABINE IN COMBINATION WITH GENISTEIN IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS AND LEUKEMIA

Registry ID

DEC-GEN 001

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

CENTRE HOSPITALIER UNIVERSITAIRE SAINTE-JUSTINE

Start date

2015-02-04

Completion date

2017-10-24

Last update

2014-11-13

Conditions

• RELAPSED OR REFRACTORY SOLID TUMORS
• LEUKEMIA

Related clinical trials

• A PHASE I STUDY OF GCAR1, A CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR PARTICIPANTS WITH SELECTED RELAPSED/REFRACTORY GPNMB-EXPRESSING SOLID TUMOURS
• PHASE I/II STUDY OF SILMITASERTIB (CX-4945) IN COMBINATION WITH CHEMOTHERAPY IN CHILDREN AND YOUNG ADULTS WITH RELAPSED REFRACTORY SOLID TUMORS
• A PHASE 2 STUDY OF REVUMENIB (SNDX-5613) IN COMBINATION WITH CHEMOTHERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY KMT2A-REARRANGED INFANT LEUKEMIA
• A PHASE 1 TRIAL OF THE MENIN INHIBITOR ZIFTOMENIB IN COMBINATION WITH CHEMOTHERAPY FOR CHILDREN WITH RELAPSED/REFRACTORY KMT2A-REARRANGED, NUP98-REARRANGED, OR NPM1-MUTANT ACUTE LEUKEMIA
• A PHASE I-II, FIRST-IN-HUMAN STUDY OF SKB264 IN PATIENTS WITH LOCALLY ADVANCED UNRESECTABLE /METASTATIC SOLID TUMORS WHO ARE REFRACTORY TO AVAILABLE STANDARD THERAPIES.
• A PHASE 1/2 OPEN-LABEL STUDY TO INVESTIGATE THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF ADMINISTRATION OF SUBCUTANEOUS BLINATUMOMAB FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B ALL

View on source registry